Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium

PLoS ONE

Volumn 12, Issue 2, 2017, Pages

  Gaksch, Martin ^a   Jorde, Rolf ^b   Grimnes, Guri ^b   Joakimsen, Ragnar ^b   Schirmer, Henrik ^b   Wilsgaard, Tom ^b   Mathiesen, Ellisiv B ^b   Njølstad, Inger ^b   Løchen, Maja Lisa ^b   Maürz, Winfried ^a,c,d   Kleber, Marcus E ^c,e   Tomaschitz, Andreas ^a,f,g   Gruübler, Martin ^a,h   Eiriksdottir, Gudny ⁱ   Gudmundsson, Elias F ⁱ   Harris, Tamara B ^j   Cotch, Mary F ^k   Aspelund, Thor ^i,l   Gudnason, Vilmundur ^i,l   Rutters, Femke ^m   Beulens, Joline W J ^m,n   Van't Riet, Esther ^m   Nijpels, Giel ^m   Dekker, Jacqueline M ^m   Grove Laugesen, Diana ^o   Rejnmark, Lars ^o   Busch, Markus A ^p   Mensink, Gert B M ^p   Scheidt Nave, Christa ^p   Thamm, Michael ^p   Swart, Karin M A ^m   Brouwer, Ingeborg A ^q   Lips, Paul ^m   Van Schoor, Natasja M ^m   Sempos, Christopher T ^r   Durazo Arvizu, Ramoón A ^s   Škrabaókovaó, Zuzana ^t   Dowling, Kirsten G ^t   Cashman, Kevin D ^t   Kiely, Mairead ^t,u   Pilz, Stefan ^a,m   more..

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d SYNLAB ACADEMY   (Germany)

^e UNIVERSITY HOSPITAL ULM   (Germany)

^f Specialist Clinic for Rehabilitation Bad Aussee   (Austria)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h BERN UNIVERSITY HOSPITAL   (Switzerland)

ⁱ ICELANDIC HEART ASSOCIATION   (Iceland)

^j NATIONAL INSTITUTE ON AGING   (United States)

^k NATIONAL EYE INSTITUTE   (United States)

^l UNIVERSITY OF ICELAND   (Iceland)

^m VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o AARHUS UNIVERSITY HOSPITAL   (Denmark)

^p ROBERT KOCH INSTITUTE   (Germany)

^q UNIVERSITY OF AMSTERDAM   (Netherlands)

^r NATIONAL INSTITUTES OF HEALTH   (United States)

^s LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^t UNIVERSITY COLLEGE CORK   (Ireland)

^u UNIVERSITY COLLEGE CORK   (Ireland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ARTICLE; CANCER MORTALITY; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; FOLLOW UP; HAZARD RATIO; HUMAN; MORTALITY; MORTALITY RISK; SYSTEMATIC REVIEW; AGED; ANALOGS AND DERIVATIVES; EUROPE; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; PROSPECTIVE STUDY; STANDARD; STANDARDS; SURVIVAL RATE; VITAMIN D DEFICIENCY;

AGED; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE STANDARDS; SURVIVAL RATE; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85012982827     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0170791     Document Type: Article

References (40)

1. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011; 96(1): 53-8. doi: 10.1210/jc.2010-2704 PMID: 21118827
2. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB,et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev. 2013 Aug; 12(10): 976-89. doi: 10.1016/j. autrev.2013.02.004 PMID: 23542507
3. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7): 1911-30. doi: 10.1210/jc.2011-0385 PMID: 21646368
4. Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol. 2014; 2(1): 76-89. doi: 10.1016/S2213-8587(13)70165-7 PMID: 24622671
5. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: Umbrella review of systematic reviews and meta-Analyses of observational studies and randomised trials. BMJ. 2014; 348: G2035. doi: 10.1136/bmj.g2035 PMID: 24690624
6. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al. Vitamin D and risk of cause specific death: Systematic review and meta-Analysis of observational cohort and randomised intervention studies. BMJ. 2014; 348: G1903. doi: 10.1136/bmj.g1903 PMID: 24690623
7. Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B, Yetley EA, Looker AC, Schleicher RL, et al. Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES. J Clin Endocrinol Metab. 2013; 98(7): 3001-9. doi: 10. 1210/jc.2013-1333 PMID: 23666975
8. Schöttker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot Ld, et al. Vitamin D and mortality: Metaanalysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ. 2014; 348: G3656. doi: 10.1136/bmj.g3656 PMID: 24938302
9. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S. Vitamin D deficiency and mortality risk in the general population: A meta-Analysis of prospective cohort studies. Am J Clin Nutr. 2012; 95(1): 91-100. doi: 10.3945/ajcn.111.014779 PMID: 22170374
10. Garland CF, Kim JJ, Mohr SB, Gorham ED, Grant WB, Giovannucci EL, et al. Meta-Analysis of allcause mortality according to serum 25-hydroxyvitamin D. Am J Pub Health. 2014; 104(8): E43-50.
11. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, et al. Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization. J Clin Endocrinol Metab. 2004; 89(7): 3152-7. doi: 10.1210/jc.2003-031979 PMID: 15240586
12. Schöttker B, Jansen EH, Haug U, Schomburg L, Köhrle J, Brenner H. Standardization of misleading immunoassay based 25-hydroxyvitamin D levels with liquid chromatography tandem-mass spectrometry in a large cohort study. PLoS One. 2012; 7(11): E48774. doi: 10.1371/journal.pone.0048774 PMID: 23133659
13. Binkley N, Sempos CT. Vitamin D Standardization Program (VDSP). Standardizing vitamin D assays: The way forward. J Bone Miner Res. 2014; 29(8): 1709-14. doi: 10.1002/jbmr.2252 PMID: 24737265
14. Cashman KD, Kiely M, Kinsella M, Durazo-Arvizu RA, Tian L, Zhang Y, et al. Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data: A case study of the program's potential for national nutrition and health surveys. Am J Clin Nutr. 2013; 97(6): 1235-42. doi: 10.3945/ajcn.112.057182 PMID: 23615829
15. Riley RD, Lambert PC, Abo-Zaid G. Meta-Analysis of individual participant data: Rationale, conduct, and reporting. BMJ. 2010; 340: C221. doi: 10.1136/bmj.c221 PMID: 20139215
16. Debray TP, Moons KG, Abo-Zaid GM, Koffijberg H, Riley RD. Individual participant data meta-Analysis for a binary outcome: One-stage or two-stage? PLoS One. 2013; 8(4): E60650. doi: 10.1371/journal. pone.0060650 PMID: 23585842
17. Cashman KD, Dowling KG,Skrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin deficiency in Europe: Pandemic? Am J Clin Nutr. 2016 Apr; 103(4): 1033-44. doi: 10.3945/ajcn.115. 120873 PMID: 26864360
18. Hicks KA, Hung HMJ, Mahaffey KW, Mehran R, Nissen SE, Stockbridge NL,et al. Standardized definitions for end point events in cardiovascular trials. (Accessed June 9th, 2014, at http://www.clinpage. com/images/uploads/endpoint-defs-11-16-2010.pdf).
19. Riley RD. Commentary: Like it and lump it? Meta-Analysis using individual participant data. Int J Epidemiol. 2010; 39(5): 1359-61. doi: 10.1093/ije/dyq129 PMID: 20660642
20. Royston P. Flexible parametric alternatives to the Cox model, and more. Stata J. 2001; 1: 1-28.
21. Abo-Zaid G, Guo B, Deeks JJ, Debray TP, Steyerberg EW, Moons KG, et al. Individual participant data meta-Analyses should not ignore clustering. J Clin Epidemiol. 2013; 66(8): 865-873. doi: 10.1016/j. jclinepi.2012.12.017 PMID: 23651765
22. Liu Q. A two-stage hierarchical regression model for meta-Analysis of epidemiologic nonlinear doseresponse data. Comput Stat Data Anal. 2009; 53: 4157-67.
23. Bagnardi V. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol. 2004; 159: 1077-86. doi: 10.1093/aje/kwh142 PMID: 15155292
24. Harrell FE. Regression Modeling Strategies with Applications to Linear Models, Logistic egression and Survival Analysis. New York: Springer-Verlag 2001.
25. Jason PF, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999; 94(446): 496-509.
26. Thomas D, Radji S, Benedetti A. Systematic review of methods for individual patient data meta-Analysis with binary outcomes. BMC Med Res Methodol. 2014; 14: 79. doi: 10.1186/1471-2288-14-79 PMID: 24943877
27. Harrell FE., Jr, DASPLINE Macro for SAS. (Accessed January 16th, 2015, at http://biostat.mc. vanderbilt.edu/twiki/pub/Main/SasMacros/survrisk.txt)
28. Zhou B, Latouche A, Rocha V, Fine J. Competing risks regression for stratified data. Biometrics. 2011; 67(2): 661-70. doi: 10.1111/j.1541-0420.2010.01493.x PMID: 21155744
29. Grant WB, Karras SN, Bischoff-Ferrari HA, Annweiler C, Boucher BJ, Juzeniene A, et al. Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects? Dermatoendocrinol. 2016; 8(1): E1187349. doi: 10.1080/19381980.2016.1187349 PMID: 27489574
30. Kroll MH, Bi C, Garber CC, Kaufman HW, Liu D, Caston-Balderrama A, et al. Temporal Relationship between Vitamin D Status and Parathyroid Hormone in the United States. PLoS One. 2015; 10(3): E0118108. doi: 10.1371/journal.pone.0118108 PMID: 25738588
31. Grant WB. Effect of interval between serum draw and follow-up period on relative risk of cancer incidence with respect to 25-hydroxyvitamin D level; implications for meta-Analyses and setting vitamin D guidelines. Dermatoendocrinol. 2011; 3(3): 199-204. doi: 10.4161/derm.3.3.15364 PMID: 22110780
32. Grant WB. Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyitamin D and all-cause mortality rate. Dermatoendocrinol. 2012; 4(2): 198-202. doi: 10.4161/derm.20514 PMID: 22928077
33. Eliassen AH, Warner ET, Rosner B, Collins LC, Beck AH, Quintana LM,et al. Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years. Cancer Res. 2016; 76: 5423-5430. doi: 10.1158/0008-5472.CAN-16-0353 PMID: 27530324
34. Bolland MJ, Grey A, Gamble GD, Reid IR. The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: A trial sequential meta-Analysis. Lancet Diabetes Endocrinol. 2014; 2(4): 307-20. doi: 10.1016/S2213-8587(13)70212-2 PMID: 24703049
35. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev. 2014; 1: CD007470.
36. Rejnmark L, Avenell A, Masud T, Anderson F, Meyer HE, Sanders KM, et al. Vitamin D with calcium reduces mortality: Patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab. 2012; 97(8): 2670-81. doi: 10.1210/jc.2011-3328 PMID: 22605432
37. Kupferschmidt K. Uncertain verdict as vitamin D goes on trial. Science. 2012; 337(6101): 1476-8.30. doi: 10.1126/science.337.6101.1476 PMID: 22997323
38. Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014; 72(1): 48-54. doi: 10.1111/nure.12090 PMID: 24330136
39. Pilz S, Rutters F, Dekker JM. Disease prevention: Vitamin D trials. Science. 2012; 338(6109): 883.
40. Amrein K, Schnedl C, Holl A, Riedl R, Christopher KB, Pachler C, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: The VITdAL-ICU randomized clinical trial. JAMA. 2014; 312(15): 1520-30. doi: 10.1001/jama.2014.13204 PMID: 25268295